This HTML5 document contains 187 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q52716381
rdf:type
wikibase:Item
schema:description
artikulong pang-agham artikel ilmiah 2018年学术文章 scientific article published on 26 April 2018 articolo scientifico vitskapeleg artikkel vedecký článok bài báo khoa học บทความทางวิทยาศาสตร์ 2018年学术文章 2018年學術文章 2018 nî lūn-bûn 2018年學術文章 научна статия wissenschaftlicher Artikel wetenschappelijk artikel επιστημονικό άρθρο article scientific 2018年學術文章 2018年学术文章 vetenskaplig artikel مقالة علمية نشرت في 26 أبريل 2018 artigo científico наукова стаття, опублікована у квітні 2018 2018年学术文章 artículu científicu tieteellinen artikkeli scienca artikolo artikull shkencor teaduslik artikkel мақолаи илмӣ 2018年学术文章 scientific article published on 26 April 2018 ২৬ এপ্রিল ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak научни чланак tudományos cikk научная статья article científic artigo científico artículo científico publicado en 2018 vědecký článek bilimsel makale научни чланак artigo científico 2018年學術文章 სამეცნიერო სტატია 2018年学术文章 scientific article published on 26 April 2018 2018年學術文章 videnskabelig artikel artykuł naukowy article scientifique vitenskapelig artikkel מאמר מדעי 2018年の論文 2018년 논문 articol științific
p:P577
wds:Q52716381-F29DAA50-4DE5-4700-88B8-DA399390F3A6
wdt:P577
2018-04-26T00:00:00Z
p:P407
wds:Q52716381-455A72ED-B89A-4CD2-A679-138127B54925
wdt:P407
wd:Q1860
p:P2888
wds:Q52716381-555BBF7E-E1F5-4339-B502-65A3974CD56E
wdt:P2888
n9:s41598-018-24968-x
p:P2860
wds:Q52716381-CAD89CE4-3175-46BC-8CA6-B98243B43054 wds:Q52716381-CC376FEF-2290-4F87-92B6-99C90A6AE580 wds:Q52716381-CC56B906-0E2D-478C-8465-B2263EBC0484 wds:Q52716381-CE1F2B4C-4491-4883-BEE6-D9C72178D803 wds:Q52716381-CEA72A77-9985-4B76-BAE2-B615BA891964 wds:Q52716381-E4A77FF1-980D-40B2-AD36-0A1C4781F542 wds:Q52716381-145171CA-AFF0-4647-85DA-762B51466A05 wds:Q52716381-19136672-99D8-40C1-AD95-D92A6578D152 wds:Q52716381-64C5C0C1-96EA-4B69-BCB5-0159D1D9751E wds:Q52716381-6F18D76A-2B41-48A4-80B7-985351313AFB wds:Q52716381-6FA94E7E-1B9E-47C0-BC86-AF5585EB7EFF wds:Q52716381-74362E78-1A5F-4371-AC8D-95D8F9EB3DC0 wds:Q52716381-778D22EF-4EFB-491B-ADD1-FAFCDAF10DBB wds:Q52716381-87FD8272-BD9E-468D-9015-C92D6060C6A2 wds:Q52716381-8A941C20-401D-4159-B5E2-9B04C8300FFA wds:Q52716381-8DAA2D55-2B7F-423E-9E0E-550DA43C08BB wds:Q52716381-8F0604B8-BCDD-4274-89C7-2AD5B5BAE467 wds:Q52716381-91A9F0BD-C3D5-4CC5-BC52-DEA12F6D2D3B wds:Q52716381-996D58E3-6108-4EA9-ADAB-3E0327F5758D wds:Q52716381-99DCA20A-D792-4638-BB5E-7FCE90CD499E wds:Q52716381-29FA6C2E-B078-417B-9C2F-7424D80DFD16 wds:Q52716381-2F16E14E-210F-4347-AD38-315DDCBFC6A8 wds:Q52716381-376C0888-A7E8-4B8F-8E2F-BF4BCE354732 wds:Q52716381-3919F8E7-5C48-4459-93CB-F3D7173A9F04 wds:Q52716381-41794BBE-9C2C-43D7-B1D5-A4792B5C84C5 wds:Q52716381-4650C9E5-C505-4589-A212-7FC241C5FCA5 wds:Q52716381-56191549-5C89-49B4-9E6E-62E40F05F524 wds:Q52716381-E55EA156-C5E6-4CFF-9403-F9E91C493BF6 wds:Q52716381-E574C1CD-E6A4-4243-9E44-E94FDD376F21 wds:Q52716381-EE4DB19B-B862-4030-9798-B6E57BDB5237 wds:Q52716381-F738BEBE-9BEC-4123-9EC6-FBEF9C91F7C8 wds:Q52716381-B17E767C-D142-4BD6-B9EE-92802757D49A
wdt:P2860
wd:Q37224735 wd:Q38656425 wd:Q38225376 wd:Q35710898 wd:Q37533321 wd:Q38829849 wd:Q33989927 wd:Q39500797 wd:Q50915770 wd:Q28299421 wd:Q36613598 wd:Q39034850 wd:Q53581875 wd:Q40144433 wd:Q38070976 wd:Q40461355 wd:Q47973074 wd:Q39733674 wd:Q38158546 wd:Q41483629 wd:Q39447473 wd:Q34974436 wd:Q37143534 wd:Q62604467 wd:Q36036437 wd:Q29617440 wd:Q24321567 wd:Q33644305 wd:Q27824766 wd:Q34051451 wd:Q38345553 wd:Q27860693
p:P2093
wds:Q52716381-BF6EAB0F-D85E-4CD3-BC5E-8F62C3ABFAB5 wds:Q52716381-C5BE51BD-5561-42DE-8383-87CC5F5046E2 wds:Q52716381-B8CB8D70-F20C-4E3D-B4CC-4D7EB016CB8A wds:Q52716381-B90AB46C-D6A5-4BD7-B016-9EBE9C025377 wds:Q52716381-B1851AEB-223C-4889-B735-0BF2867D60E8 wds:Q52716381-B50CA990-4D4E-43E8-A9F0-A54284096ED7 wds:Q52716381-DCFEF031-4517-4C9C-AD63-E6C0EFDE6BE3 wds:Q52716381-D290CB1B-6D33-4837-B3A2-4DB1BE2E4C8F wds:Q52716381-1B6E2211-117E-4455-B198-CEAA4F71AFCC wds:Q52716381-5F0CB065-269A-4539-83FA-3520056D92BC
wdt:P2093
Laura Pandolfi Davide Prosperi Francesco Pappalardo Fabio Corsi Miriam Colombo Chiara Pacini Marta Truffi Luca Sorrentino Arianna Bonizzi Raffaele Allevi
rdfs:label
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells. Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.
skos:prefLabel
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells. Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.
schema:name
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells. Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.
p:P50
wds:Q52716381-53026730-1144-41CF-B57A-429929634E30
wdt:P50
wd:Q39376745
p:P1476
wds:Q52716381-2D6F4BB7-DF34-43BC-9169-C3FB7AFDAF8C
wdt:P1476
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells.
p:P304
wds:Q52716381-3600BFAC-4D42-46F5-809B-CE0CEE5006C5
wdt:P304
6563
p:P31
wds:Q52716381-1302CC45-0A68-4736-910A-073D6C146B28
wdt:P31
wd:Q13442814
p:P921
wds:Q52716381-EA1880C2-71FC-4E6A-8D7F-4B81CF08757E
wdt:P921
wd:Q412616
p:P698
wds:Q52716381-64729E68-1610-4579-8363-2640EA242644
wdtn:P698
n13:29700387
wdt:P698
29700387
p:P1433
wds:Q52716381-0D8DBAC0-F420-4A78-B2F9-AE4CEA6A9899
wdt:P1433
wd:Q2261792
p:P433
wds:Q52716381-3128B97C-626C-4C09-829F-02D6FDF971B0
p:P478
wds:Q52716381-5020FF62-1148-4055-B7CD-0AB79CBE70A0
wdt:P433
1
wdt:P478
8
p:P356
wds:Q52716381-2D0A511C-8F7D-49F3-8D9B-D4ECFD5FB92D
wdtn:P356
n12:S41598-018-24968-X
wdt:P356
10.1038/S41598-018-24968-X
p:P275
wds:Q52716381-8a912d82-8419-424e-b400-c23e9913f702
p:P6216
wds:Q52716381-a2b7765a-d671-47c7-9642-565d84d6eb36
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P4510
wds:Q52716381-60310CAB-EC1C-4A5A-B24D-9456713EF306
wdt:P4510
wd:Q1659584
p:P6179
wds:Q52716381-A2784CDF-1A34-4AAB-AE59-373CED90744C
wdt:P6179
1103565913
p:P932
wds:Q52716381-FF58CD3A-FAD1-4014-BB74-569A294E461C
wdt:P932
5920071